ALPHA TRIBE

Astec LifeSciences LimitedUpdates, 30-01-2026: Press Release

30-01-2026 | 08:43 pm

Astec LifeSciences announced its Q3/9M FY26 results. Q3 consolidated income rose 31% to Rs. 125.5 Cr, with EBITDA turning positive at Rs. 4.8 Cr from a loss. Net loss significantly reduced to Rs. 15.7 Cr. Strong revenue growth driven by higher Enterprise and CDMO volumes.

No comments yet. Be the first to comment!

All announcements from Astec LifeSciences Limited